Acupuncture for Rhinitis Complicated With Asthma
Acupuncture for Persistent Allergic Rhinitis Complicated With Asthma, A Randomized Controlled Pilot Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This randomized controlled study aimed to evaluate the efficacy and safety of acupuncture therapy on persistent allergic rhinitis patients complicated with asthma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 7, 2014
CompletedFirst Posted
Study publicly available on registry
January 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedSeptember 2, 2015
August 1, 2015
1.9 years
January 7, 2014
August 31, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Total Nasal Symptom Score (TNSS)
Change from Baseline TNSS Score at 4 Weeks after Randomization
Secondary Outcomes (6)
Rhinitis Quality of Life Questionnaire (RQLQ)
Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)
Quality of Life Questionnaire for adult Korean Asthmatics (QLQAKA)
Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)
Visual Analogue Scale
Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)
Pulmonary function test (PFT)
Baseline, four weeks after randomization (both groups)
Euro Quality of Life-5 Dimention Questionnaire (EQ-5D)
Baseline, four weeks after randomization
- +1 more secondary outcomes
Study Arms (2)
Acupuncture
EXPERIMENTALA series of acupuncture sessions within four weeks from the baseline with concurrent conventional medications for asthma
Waiting
NO INTERVENTIONParticipants who will be allocated to waitlist will receive no acupuncture treatments throughout the 4 weeks while receiving other conventional managements for asthma. After 4 weeks, if participants choose to try the acupuncture treatment, the active acupuncture treatment will be provided for 4 weeks (3 sessions/week).
Interventions
In the acupuncture treatment group, 10 acupuncture points (bilateral LI4, TE23, ST36, unilateral EHN-1, GV23, LI20 and LI4) will be inserted with 0.20 mm in diameter x 30 mm in length disposal needles. The needle will be inserted to a depth of 10 - 30 mm, according to the points selected. The participating acupuncture doctors will manually manipulate the acupuncture needles with de-qi sensation and maintain the needles for 10 minutes with two times of manual stimulation, at the beginning and at the end.
Eligibility Criteria
You may qualify if:
- Suffering from persistent Allergic rhinitis (PAR; nasal obstruction, rhinorrhoea, sneezing and nasal itching) symptoms for more than 4 days/week, and greater than 4 consecutive weeks.
- Moderate-severe symptoms according to Allergic rhinitis and its impact on asthma (ARIA) criteria.
- Positive reaction for more than or equal to one respiratory allergen (SPT or MAST)
- Stable asthma symptoms with diagnosis of Asthma by respiratory or allergic disease specialist.
- No changes in asthma or allergic rhinitis drugs for the past month
- Aged greater than or equal to 18 years, either sex.
- No problem with expression of opinion
- Provided with written consent
- No other disease except allergic rhinitis or asthma which could affect the disease.
You may not qualify if:
- Having experience using ventilator due to exacerbation of asthma symptoms within six months.
- Experience of acute respiratory tract infection treated with antibiotics within 14 days
- Having anatomical occlusion or deformation in nasal cavity.
- Signs of infection in chest X-ray or having active respiratory disease except asthma
- Below or equal to 4 on Total nasal symptom score (TNSS) in the latest week.
- Received drugs affecting directly to allergic rhinitis such as H1-antihistamines, decongestants (nasal, oral or ocular), corticosteroids within 14 days.
- Received following treatments for allergic rhinitis or asthma within six months ; Traditional Korean medicine interventions such as acupuncture, moxibustion, cupping therapy and herbal medication inhalation or CAM including homeopathy.
- Received herbal medication for allergic rhinitis or asthma within 14 days.
- Pregnant, planning the pregnancy or breast-feeding
- Tuberculosis, hepatitis or more than 2 x normal limit of serum creatinine, aspartate aminotransferase/alanine aminotransferase (AST/ALT).
- Skin lesion on acupoint or other systemic disease insufficient for acupuncture.
- Night-shift workers staying up all night
- Who cannot participate clinical trial properly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jun-Yong Choilead
Study Sites (1)
National Clinical Research Center, Korean Medicine Hospital, Pusan National University
Yangsan, Kyungsangnamdo, 626-770, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun-Yong Choi, KMD, PhD
Korean Medicine Hospital, Pusan National University
- PRINCIPAL INVESTIGATOR
Yun Seong Kim, MD, PhD
Yangsan Pusan National University Hospital
- STUDY DIRECTOR
Seung Eun Lee, MD
Yangsan Pusan National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 7, 2014
First Posted
January 10, 2014
Study Start
January 1, 2014
Primary Completion
December 1, 2015
Last Updated
September 2, 2015
Record last verified: 2015-08